专题：Amyloidosis: Diagnosis, Treatment, Outcomes

This cluster of papers focuses on the molecular mechanisms, diagnosis, treatment, and prognosis of amyloidosis, with a particular emphasis on transthyretin-related cardiac and familial amyloid polyneuropathy. It covers topics such as RNAi therapy, cardiovascular magnetic resonance, and immunoglobulin light chain involvement.
最新文献
A novel spliceosomopathy caused by de novo SF3B3 variants

article Full Text OpenAlex

Quantitative SPECT/CT for diagnosis of transthyretin amyloid cardiomyopathy: a pathology-based study

article Full Text OpenAlex

Mammals that can develop type 2 diabetes have a similarly structured β-sheet amyloid oligomer

article Full Text OpenAlex

“Tiger man sign” in sarcoid myopathy

article Full Text OpenAlex

Outcomes of Left Atrial Appendage Occlusion in Patients With Hypertrophic Cardiomyopathy, Rheumatic Heart Disease, and Cardiac Amyloidosis

article Full Text OpenAlex

Interpreting tafamidis effectiveness within the evolving phenotype of contemporary ATTRwt cardiomyopathy

article Full Text OpenAlex

Ocular manifestations of transthyretin amyloidosis and their diagnostic value in cardiology: A comprehensive review

article Full Text OpenAlex

Elecsys pTau217 plasma immunoassay detection of amyloid pathology in clinical cohorts

article Full Text OpenAlex

Preparing for the implementation of anti-amyloid therapies in Europe: Assessing real-world eligibility for lecanemab and donanemab in a Swedish memory clinic

article Full Text OpenAlex

Multimodal Diagnosis of Cardiac Amyloidosis: Integrating Imaging, Histochemistry, and Proteomics of Precise Typing

article Full Text OpenAlex

近5年高被引文献
2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient With Cardiac Amyloidosis

article Full Text OpenAlex 488 FWCI76.2452

Performance of plasma phosphorylated tau 181 and 217 in the community

article Full Text OpenAlex 464 FWCI66.3987

Efficacy and Safety of Acoramidis in Transthyretin Amyloid Cardiomyopathy

article Full Text OpenAlex 377 FWCI90.4002

Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial

article Full Text OpenAlex 348 FWCI27.9316

Amyloid nomenclature 2022: update, novel proteins, and recommendations by the International Society of Amyloidosis (ISA) Nomenclature Committee

article Full Text OpenAlex 301 FWCI25.6165

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

article Full Text OpenAlex 296 FWCI71.3559

Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics

review Full Text OpenAlex 291 FWCI51.8793

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis

article Full Text OpenAlex 274 FWCI42.4973

Extramedullary disease in multiple myeloma: a systematic literature review

review Full Text OpenAlex 254 FWCI38.0099

Phase 1 Trial of Antibody NI006 for Depletion of Cardiac Transthyretin Amyloid

article Full Text OpenAlex 215 FWCI33.5879